33
Participants
Start Date
September 30, 2012
Primary Completion Date
September 9, 2022
Study Completion Date
September 9, 2022
Aspirin 75mg
Subjects randomised to aspirin 75mg will receive 1 container containing aspirin 75mg and 1 container containing placebo for the morning and 2 containers containing placebo for the evening. Subjects will take one capsule from each container in the morning and one capsule from each container in the evening.
Lactose powder
Subjects randomised to placebo will receive 4 containers of placebo, 2 containers containing placebo for the morning and 2 containers containing placebo for the evening. Subjects will take one capsule from each container in the morning and one capsule from each container in the evening.
Aspirin 1200mg
Subjects randomised to aspirin 600mg 12 hourly will receive 2 containers of aspirin 300mg each for the morning and 2 containers of aspirin 300mg each for the evening. Subjects will take one capsule from each container in the morning and one capsule from each container in the evening.
Belfast Health and Social Care Trust, Belfast
Collaborators (1)
The Intensive Care Society United Kingdom
UNKNOWN
Northern Ireland Clinical Trials Unit
OTHER
Queen's University, Belfast
OTHER
Belfast Health and Social Care Trust
OTHER